Trial CTSU-EA8212


A Randomized Phase III Trial of Intravesical BCG versus Intravesical Docetaxel and Gemcitabine Treatment in BCG Naive High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE)

Type: Treatment
Phase: Phase III
Status: Open to Accrual
Treatments: Chemotherapy: Local, Other
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Siamak Daneshmand, M.D.
Other Trial Staff:  Cheryl Kefauver, Coordinator, Monica Flores, D.M., Lusine Raddatz, D.M., Rubina Hassan, D.M., Lagrimas Ilagan, D.M., Mary Ordaz, D.M., Roberto Tejada, Coordinator, Shamim Jhimlee, Coordinator, Honorina Enright, D.M., Amanda Luna, Coordinator, Niranjan Bhatt, D.M., Bartolo Santos, Coordinator, Ikechukwu Okereke, Coordinator, Sarah Chevalier, Coordinator, Samantha Escano, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.